|
Mar 2
|
Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds
|
|
Feb 28
|
Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025?
|
|
Feb 28
|
Q4 2024 OPKO Health Inc Earnings Call
|
|
Feb 28
|
Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?
|
|
Feb 28
|
Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts
|
|
Feb 27
|
Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds
|
|
Feb 27
|
3 Leading Dividend Stocks To Consider With Up To 5.6% Yield
|
|
Feb 26
|
Is Merck & Co., Inc. (MRK) the Best Retirement Stock to Buy According to Hedge Funds?
|
|
Feb 26
|
Why Polaris, Merck, And Skyworks Solutions Are Winners For Passive Income
|
|
Feb 26
|
Merck & Co., Inc. (MRK): Among Bourgeon Capital’s Top Stock Picks
|
|
Feb 26
|
Despite delivering investors losses of 27% over the past 1 year, Merck (NYSE:MRK) has been growing its earnings
|
|
Feb 26
|
Cancer vaccines have stumbled, but the approach is gaining new steam
|
|
Feb 26
|
Eikon raises $351M in one of the year’s largest biotech venture rounds
|
|
Feb 25
|
Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Maybe The Ultimate Laggard’
|
|
Feb 25
|
Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest?
|
|
Feb 25
|
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
|
|
Feb 17
|
Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?
|
|
Feb 15
|
Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes
|
|
Feb 13
|
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
|
|
Feb 13
|
Merck & Co., Inc. (MRK): A Bull Case Theory
|